Krafchik B, Pelletier J
Department of Dermatology, Hospital for Sick Children, Toronto, Canada.
Dermatology. 1997;194 Suppl 1:43-4. doi: 10.1159/000246185.
In an ongoing study of Lamisil in children, 21 patients have so far been enrolled and preliminary data are reported in this paper. Eighteen have tinea capitis and 1 has tinea corporis. So far, Trichophyton tonsurans has been identified in 17 and Trichophyton violaceum in 2. Lamisil has so far proved to be well tolerated, efficacious and cost-effective in a 2-week course in those children with a Trichophyton species. If Microsporum canis is isolated, a longer course is probably indicated. Lamisil has the distinct advantage of producing good results in a short time period, making patient compliance less of a problem.
在一项正在进行的关于儿童使用兰美抒的研究中，到目前为止已招募了21名患者，本文报告了初步数据。其中18例患有头癣，1例患有体癣。到目前为止，已在17例中鉴定出断发毛癣菌，2例中鉴定出紫色毛癣菌。对于那些感染毛癣菌属的儿童，兰美抒在为期2周的疗程中已被证明耐受性良好、有效且具有成本效益。如果分离出犬小孢子菌，可能需要更长的疗程。兰美抒的显著优点是能在短时间内产生良好效果，使患者的依从性问题减少。
